• LAST PRICE
    212.4300
  • TODAY'S CHANGE (%)
    Trending Down-1.4700 (-0.6872%)
  • Bid / Lots
    188.0000/ 1
  • Ask / Lots
    233.0000/ 1
  • Open / Previous Close
    216.1000 / 213.9000
  • Day Range
    Low 211.0000
    High 216.3100
  • 52 Week Range
    Low 119.7604
    High 299.9800
  • Volume
    253,578
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 213.9
TimeVolumeMDGL
09:32 ET839216.1
09:38 ET300213.87
09:39 ET5800215.89
09:41 ET225215.89
09:43 ET100214.805
09:48 ET285212.973
09:50 ET500216.2399
09:52 ET500214.225
09:56 ET335214.87
10:01 ET100214.995
10:03 ET203215.33
10:06 ET100215.245
10:08 ET101215.245
10:12 ET200215.67
10:14 ET300215.34
10:15 ET100215.14
10:17 ET500215.195
10:19 ET125215.2925
10:21 ET100215.12
10:24 ET400216.3099
10:26 ET381216.1
10:30 ET200216.31
10:32 ET1028215.54
10:33 ET100215.345
10:39 ET100215.58
10:44 ET715215.8
10:48 ET500215.955
10:50 ET300215.965
10:53 ET200215.705
10:57 ET200215.57
11:02 ET200215.76
11:04 ET100215
11:09 ET100214.94
11:11 ET480215.29
11:18 ET5800215.79
11:20 ET500215.735
11:22 ET300215.22
11:24 ET1400214.99
11:26 ET300214.81
11:27 ET200215.07
11:31 ET200215.435
11:33 ET1000215.585
11:36 ET500216.055
11:38 ET322215.6
11:47 ET200215.58
11:49 ET400215.6
11:54 ET100215.49
11:56 ET322215.64
11:58 ET222216.09
12:00 ET222216.09
12:02 ET2050215.455
12:03 ET100215.33
12:05 ET200215.2153
12:12 ET1278214.99
12:16 ET300214.81
12:18 ET700214.905
12:21 ET184215.09
12:25 ET100214.93
12:27 ET1500214.94
12:30 ET100214.955
12:32 ET163214.97
12:36 ET11490215.1
12:38 ET300215.21
12:43 ET279215.4935
12:45 ET100215.255
12:50 ET510214.9
12:52 ET100215.005
01:01 ET300215.22
01:08 ET134215.25
01:10 ET100214.84
01:12 ET324214.985
01:14 ET1453215.135
01:15 ET580215.2284
01:17 ET359215.2
01:19 ET598214.6
01:21 ET883215.01
01:28 ET100215.095
01:30 ET521215.465
01:37 ET386215.375
01:39 ET136215.295
01:42 ET100215.52
01:48 ET2947215.5
01:50 ET9080215.58
01:51 ET2020215.36
01:53 ET500215.5
01:55 ET300215.5
01:57 ET100215.26
02:08 ET100214.69
02:09 ET300214.69
02:20 ET992214.62
02:26 ET582214.115
02:27 ET500214.41
02:31 ET300212.965
02:33 ET100212.88
02:38 ET200212.905
02:42 ET100212.715
02:44 ET400212.92
02:45 ET300212.925
02:47 ET193213.29
02:56 ET100213.08
03:00 ET100213.63
03:02 ET200213.08
03:03 ET192212.52
03:05 ET450212.38
03:07 ET300212.515
03:09 ET100212.28
03:12 ET200211.96
03:14 ET100211.865
03:16 ET200211.7
03:18 ET300211.3
03:20 ET1300211.5822
03:21 ET6092212.415
03:23 ET600212.89
03:25 ET1047212.965
03:27 ET4000213.73
03:30 ET6700214.155
03:32 ET300213.565
03:34 ET1266213.585
03:36 ET3100213.015
03:38 ET1800213.43
03:39 ET100213.5
03:41 ET307212.71
03:43 ET100212.68
03:45 ET700212.22
03:48 ET1969213.08
03:50 ET200213.34
03:52 ET848213.07
03:54 ET3393212.7
03:56 ET6759212.4
03:57 ET5502212.37
03:59 ET25130212.43
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMDGL
Madrigal Pharmaceuticals Inc
5.3B
-8.3x
---
United StatesBBIO
BridgeBio Pharma Inc
4.9B
-9.5x
---
United StatesNUVL
Nuvalent Inc
5.7B
-35.6x
---
United StatesRNA
Avidity Biosciences Inc
4.9B
-14.3x
---
United StatesKRYS
Krystal Biotech Inc
5.8B
48.4x
---
United StatesIMVT
Immunovant Inc
4.3B
-14.6x
---
As of 2024-09-28

Company Information

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.

Contact Information

Headquarters
200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
Phone
404-380-9263
Fax
302-655-5049

Executives

Independent Chairman of the Board
Julian Baker
President, Chief Executive Officer, Director
Bill Sibold
Chief Financial Officer, Senior Vice President
Mardi Dier
President of Research and Development, Chief Medical Officer, Director
Rebecca Taub
General Counsel
Shannon Kelley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.3B
Revenue (TTM)
$14.6M
Shares Outstanding
21.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.44
EPS
$-25.50
Book Value
$20.39
P/E Ratio
-8.3x
Price/Sales (TTM)
358.7
Price/Cash Flow (TTM)
---
Operating Margin
-3,622.65%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.